Marita Kametas, MSN, FNP-BC, CMSRN, COCNThe importance of cancer screening and prevention in patients with inflammatory bowel disease (IBD) is highlighted by the study of Wu and colleagues. Patients who are taking immunosuppressive therapy should be screened at closer intervals than persons without IBD. Patients should complete all applicable vaccinations, including vaccination against human papillomavirus (HPV) to prevent the development of cervical cancer. Patients should be screened for dysplasia and colorectal cancer at an individualized interval determined by disease extent and duration. The findings of this study support the need for a comprehensive review of a patient's access to preventive services, dermatology services, gynecology services, and vaccines, and regular follow-up to continually review the appropriateness of therapy, based on health changes in the interval.
The study by D'Amico and colleagues underscores the importance of using biologic therapies early in the postoperative course to prevent endoscopic recurrence. Patients who require surgery should initiate biologic therapy as soon as they have completed postoperative healing. This will help prevent a recurrence of their Crohn's disease and limit the need for subsequent surgery in the future. Proactive monitoring for postoperative recurrence and prompt management of any inflammation identified is vital in improving long-term outcomes.
Meanwhile, Rosiou and colleagues highlight the importance of communication with the entire care team regarding the management of IBD flares. Proactive patient education about notifying the primary gastroenterology provider if they experience flare symptoms can help prevent inappropriate or excess steroid exposure. Steroid-sparing strategies for the induction and maintenance of IBD remission are pivotal in preventing side effects and long-term complications of steroid exposure. Steroids should be used as a short-term therapy while bridging to a safe and appropriate maintenance regimen.
Author and Disclosure Information
Marita Kametas, MSN, FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois
APN Kametas is an active member of the Abbvie Speakers’ Bureau
Marita Kametas, MSN, FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois
APN Kametas is an active member of the Abbvie Speakers’ Bureau
Author and Disclosure Information
Marita Kametas, MSN, FNP-BC, CMSRN, COCN, Advanced Practice Nurse, Department of Digestive Diseases, The University of Chicago Medicine, Chicage, Illinois
APN Kametas is an active member of the Abbvie Speakers’ Bureau
APN Kametas scans the journals, so you don’t have to!
APN Kametas scans the journals, so you don’t have to!
Marita Kametas, MSN, FNP-BC, CMSRN, COCNThe importance of cancer screening and prevention in patients with inflammatory bowel disease (IBD) is highlighted by the study of Wu and colleagues. Patients who are taking immunosuppressive therapy should be screened at closer intervals than persons without IBD. Patients should complete all applicable vaccinations, including vaccination against human papillomavirus (HPV) to prevent the development of cervical cancer. Patients should be screened for dysplasia and colorectal cancer at an individualized interval determined by disease extent and duration. The findings of this study support the need for a comprehensive review of a patient's access to preventive services, dermatology services, gynecology services, and vaccines, and regular follow-up to continually review the appropriateness of therapy, based on health changes in the interval.
The study by D'Amico and colleagues underscores the importance of using biologic therapies early in the postoperative course to prevent endoscopic recurrence. Patients who require surgery should initiate biologic therapy as soon as they have completed postoperative healing. This will help prevent a recurrence of their Crohn's disease and limit the need for subsequent surgery in the future. Proactive monitoring for postoperative recurrence and prompt management of any inflammation identified is vital in improving long-term outcomes.
Meanwhile, Rosiou and colleagues highlight the importance of communication with the entire care team regarding the management of IBD flares. Proactive patient education about notifying the primary gastroenterology provider if they experience flare symptoms can help prevent inappropriate or excess steroid exposure. Steroid-sparing strategies for the induction and maintenance of IBD remission are pivotal in preventing side effects and long-term complications of steroid exposure. Steroids should be used as a short-term therapy while bridging to a safe and appropriate maintenance regimen.
Marita Kametas, MSN, FNP-BC, CMSRN, COCNThe importance of cancer screening and prevention in patients with inflammatory bowel disease (IBD) is highlighted by the study of Wu and colleagues. Patients who are taking immunosuppressive therapy should be screened at closer intervals than persons without IBD. Patients should complete all applicable vaccinations, including vaccination against human papillomavirus (HPV) to prevent the development of cervical cancer. Patients should be screened for dysplasia and colorectal cancer at an individualized interval determined by disease extent and duration. The findings of this study support the need for a comprehensive review of a patient's access to preventive services, dermatology services, gynecology services, and vaccines, and regular follow-up to continually review the appropriateness of therapy, based on health changes in the interval.
The study by D'Amico and colleagues underscores the importance of using biologic therapies early in the postoperative course to prevent endoscopic recurrence. Patients who require surgery should initiate biologic therapy as soon as they have completed postoperative healing. This will help prevent a recurrence of their Crohn's disease and limit the need for subsequent surgery in the future. Proactive monitoring for postoperative recurrence and prompt management of any inflammation identified is vital in improving long-term outcomes.
Meanwhile, Rosiou and colleagues highlight the importance of communication with the entire care team regarding the management of IBD flares. Proactive patient education about notifying the primary gastroenterology provider if they experience flare symptoms can help prevent inappropriate or excess steroid exposure. Steroid-sparing strategies for the induction and maintenance of IBD remission are pivotal in preventing side effects and long-term complications of steroid exposure. Steroids should be used as a short-term therapy while bridging to a safe and appropriate maintenance regimen.
